Navigation Links
Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials

/p>

"EVEREST adds to the collection of data on tolvaptan and its potential uses," said Kazumichi Kobayashi, Chairman & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. "Tolvaptan, as one of our most advanced candidate therapies, exemplifies the successful application of Otsuka's expertise in new drug research and development."

About Heart Failure

More than 14 million people in Europe(6) and five million U.S. residents(7) have heart failure (HF), a serious chronic condition in which the heart cannot effectively pump blood. The direct and indirect U.S. health care expenses related to HF tally about $28 billion, ACC estimates.(5) The majority of patients hospitalized for ADHF, the worsening of chronic HF that affects 1 million US residents annually, have edema or excess body fluid.(3)

About Otsuka Pharmaceutical Development & Commercialization, Inc.

Otsuka Pharmaceutical Development and Commercialization, Inc. is involved in conducting all phases of clinical research and development of innovative healthcare products to address unmet medical needs. OPDC is well established in the scientific community as a globally focused organization that plays a leadership role in the research and development of Otsuka's ethical healthcare products. The Company is dedicated to the improvement of the quality of human life and health of patients around the world with a strong commitment to research and development in the areas of cardiovascular, neuroscience, renal and respiratory diseases, as well as cancer and ophthalmic disorders. OPDC is part of the Otsuka Pharmaceutical Group, which is comprised of 87 companies and approximately 27,000 people around the world. With 44 consolidated subsidiaries, Otsuka earned US $6.8 billion in consolidated annual revenues in fiscal 2005. For additional information, visit www.otsuka.com.

JAMA Publications:

Konstam, MA, et
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
2. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
7. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
8. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
9. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
10. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
11. UCB Presents Long-Term CImzia Data in Crohns Disease

Post Your Comments:
(Date:11/25/2009)...v.25/PRNewswire-USNewswire/--RemediumTechnologiesI...opsseverebleeding,wonfirstprizeand$10,000intheMost...allenge2009,companyofficialsannouncetoday. ,, S...medium,steampitchedtheirinventionattheGSCSecurityS..., Remedium( www.remediumtechnologies.com )isdeve...
(Date:11/25/2009)...ewswire/--Reportlinker.comannouncesthatanewmarketr...mmographyEquipment-AGlobalMarketPerspective ,...y-Equipment---A-Global-Market-Perspective.html ,...swellasdevelopingnationsisaprincipalfactorinfluenc...gawarenessaboutbreastcancerhasallowedwomentocomefo...
(Date:11/25/2009)...v.25/PRNewswire/--CempraPharmaceuticalsInc.todayan...xecutiveofficer,willpresentatthePiperJaffray21stAn...09,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernand...ibioticclinicalprogramsforthetreatmentofdrug-resis...maceuticals ,, Foundedin2006,CempraPharmaceuti...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Analysis of Copernicus putative remains support identity 9138 1Analysis of Copernicus putative remains support identity 9138 2When it comes to brain damage blankets take the place of drugs 9135 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 3
...Cryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today...ing forodesine HCl, the Company,s lead anti-cancer...ukemias and lymphomas., Madeline Duvic, M.D., Dep...D. Anderson Cancer Center presented interim data f...ne HCl in the treatment of subjects,with refractor...
...proved for the Treatment of PKU, NOVATO, Calif., ...SWX: BMRN) announced today that the U.S.,Food and ...proval for,Kuvan(TM) (sapropterin dihydrochloride)... for the treatment of phenylketonuria (PKU). Shipm...orrow, and BioMarin will begin,promotion of Kuvan ...
Other Medicine Technology:Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 2Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 3Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 4BioMarin Announces FDA Approval for Kuvan 2BioMarin Announces FDA Approval for Kuvan 3BioMarin Announces FDA Approval for Kuvan 4BioMarin Announces FDA Approval for Kuvan 5BioMarin Announces FDA Approval for Kuvan 6BioMarin Announces FDA Approval for Kuvan 7BioMarin Announces FDA Approval for Kuvan 8
(Date:11/27/2009)...ecipes.com , theworld,s#1foodsite,receivedrecord-...ionvisitorsthedaybeforeThanksgiving,providingaclea...eyear.TheaverageThanksgivingmealin2009weighedinat2...ar,sfeast.AccordingtotheAllrecipessite, SweetPotat...pe,acontrastfromlastyear,spopular HomestyleTurkeyt...
(Date:11/26/2009)...oldandfluseasonuponus,it,smoreimportantthanevertoe...davoidillness. ,, "Weneedtobeproactivenotonlyto...ifwe,resick,"saidEileenFinerty,RN,MS,CIC(certified...ntrolandoccupationalhealthatHospitalforSpecialSurg...ryhasoneofthelowestinfectionratesofanyhospitalinth...
(Date:11/26/2009)...onal rollercoaster, study finds , , THUR... factor meets the jubilant sports fan. , A new ... who root for the winning team -- enjoy the greate...and victory was in doubt, producing feelings of wo...sgiving weekend as you,re glued to the TV set, wat...
(Date:11/26/2009)...is, P.A. is offering free nationwide confidential ...ntrol pills who have suffered a Deep Vein Thrombos... or other related cardiac issues or had their Gall...-856-6405 or go to the firm’s website at ht... evaluation form. , (PRWE...
(Date:11/25/2009)...elleMedicalInc.,aleadingmanufacturerofbreastMRIcoi...newleadingedgeclinicalapplicationsonitsAegis(TM)me...alSocietyofNorthAmerica(RSNA)annualmeetinginChicag...nsleveragetheuniquehighqualityimagesgeneratedbySen...pleimagingmodalitiesformulti-parametricassessment....
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
... Fashionable medical bracelets and IDs ...ttends the "Walk to Cure Diabetes" in Ta... and the Juvenile Diabetes Research Foundation mad...specialized in selling personalized jewelry to cus...
...g Back Clock to Implement Bush Administration Prop...ader Health Reform Goals , , WASHINGTON, May 1 ...dicare regulation first proposed by the Bush Admin...ntent of the American Recovery and Reinvestment A...
...CK: Now we know what blocks the effects of a newly...eing developed to treat individuals with cancer th...adenovirus-based therapies. Although promising cli...en uncovered by a team of researchers, led by Nick...
...ING, Pa., May 1 /PRNewswire-Asia-FirstCall/ -- BMP...one" or the "Company") today announced that on Apr...f The Nasdaq Stock Market LLC indicating that the ...ing of two shares of the Company,s common stock an...
...E, Pa., May 1 Many over-the-counter pain reliever...e United States Food and Drug Administration (FDA)...ing, made Tuesday, calls for stronger labeling on ...en. , , Consumers, concerned with NSAIDs and thei...
...o Biotech Inc. Sponsors Award Honoring the Work of...nner and finalists of CURE magazine,s 2009 Extra...red by Centocor Ortho Biotech Inc., were announced...d nominations. The winner, Christine Wilson, RN, ...
Other Medicine News:Health News:Sticky Jewelry & JDRF Team Up to Find a Cure 2Health News:Sticky Jewelry & JDRF Team Up to Find a Cure 3Health News:AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency 2Health News:AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency 3Health News:JCI online early table of contents: May 1, 2009 2Health News:JCI online early table of contents: May 1, 2009 3Health News:JCI online early table of contents: May 1, 2009 4Health News:JCI online early table of contents: May 1, 2009 5Health News:BMP Sunstone Compliance Receives Nasdaq Notice 2Health News:Consumers are Looking to Boiron Arnicare(R) as a Safer Option as FDA Enforces Stricter Labeling for Many Pain Relievers 2Health News:Consumers are Looking to Boiron Arnicare(R) as a Safer Option as FDA Enforces Stricter Labeling for Many Pain Relievers 3Health News:Winner of 2009 CURE Magazine Extraordinary Healer Award Announced 2Health News:Winner of 2009 CURE Magazine Extraordinary Healer Award Announced 3
Maverick Over-The-Wire 25 mm Catheter
Maverick Over-The-Wire 12 mm Catheter
Illuminated PHOROPTOR Refracting Instrument - Plus Cylinder Black
RK600 Auto Refractor / Keratometer
Medicine Products: